Suppression of arthritis and protection from bone destruction by treatment with TNP‐470/AGM‐1470 in a transgenic mouse model of rheumatoid arthritis

Abstract

Our demonstration that in vivo administration of an angiogenesis inhibitor suppresses arthritis and protects from bone destruction provides new insight into the pathogenesis of the disease and opens new possibilities in the treatment of RA in humans.